approval
saveTOPIRAMATE — FDA approval
community read0 votes
Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMar 6, 2026 · 218d ago
- approvalTOPIRAMATE — FDA approvalJan 27, 2026 · 256d ago
- approvalTOPIRAMATE — FDA approvalJan 18, 2026 · 265d ago
- approvalTOPIRAMATE — FDA approvalJan 12, 2026 · 271d ago
- approvalTOPIRAMATE — FDA approvalOct 7, 2025 · 368d ago
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMar 12, 2025 · 577d ago
- approvalTOPIRAMATE — FDA approvalJul 16, 2024 · 816d ago
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMay 17, 2024 · 876d ago
same company · ±60 days · 6
- approvalSUCRALFATE: SUCRALFATE — FDA approvalJan 5, 2026
- approvalFINGOLIMOD HYDROCHLORIDE: FINGOLIMOD HYDROCHLORIDE — FDA approvalJan 16, 2026
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 18, 2026
- approvaltacrolimus ER: TACROLIMUS — FDA approvalOct 17, 2025
- approvaltacrolimus ER: TACROLIMUS — FDA approvalOct 17, 2025
- approvaltacrolimus ER: TACROLIMUS — FDA approvalOct 17, 2025
comments(0)
5-min edit window · permanent after that